REFERENCES
- Sera N, Ashizawa K, Ando T, . Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves’ disease. Thyroid. 2000;10:595–599.
- Calañas-Continente A, Espinosa M, Manzano-García G, Santamaria R, Lopez-Rubio F, Aljama P. Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy. Thyroid. 2005;15:286–288.
- D’Cruz D, Chesser AM, Lightowler C, . Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol. 1995;34:1090–1091.
- Day C, Bridger J, Rylance P, Jackson M, Nicholas J, Odum J. Leukocytoclastic vasculitis and interstitial nephritis with carbimazole treatment. Nephrol Dial Transplant. 2003;18:429–431.
- Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther. 2005;7:R1072–R1081.
- Herlin T, Birkebaek NH, Wolthers OD, Heegaard NH, Wiik A. Antineutrophil cytoplasmic antibodies (ANCA) prophiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand J Rheumatol. 2002;31:46–49.
- Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab. 1999;84:13–16.
- Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology. 2008;47:1515–1520.
- Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr. 1994;124:986–988.
- Batchelor N, Holley AA. Fatal case of propylthiouracil-induced ANCA-positive vasculitis. MDMedGenMed. 2006;8:10.
- Wiik A. Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther. 2005;7:191–192.
- Tieulie N, Huong DL, Andreu M, . ANCA associated glomerulonephritis related to benzylthiouracil. Rev Med Int. 2002;23:853–856.
- Trimeche Ajmi S, Braham R, Toumi S, . Benzylthiouracil-induced glomerulonephritis. Case Report Med. 2009;2009:687285.
- Jarraya F, Abid M, Jlidi R, . Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with benzylthiouracil therapy: report of the first case. Nephrol Dial Transplant. 2003;18:2421–2423.
- Kaaroud H, Khiari K, Ben Moussa F, Barbouch S, Boussema E, Ben Maïz H. Vasculitis with renal and pulmonary involvement in a patient receiving benzyl thiouracil for Graves disease. Rev Med Int. 2002;23:857–861.
- Erten Y, Bodur H, Sahiner S, Akkaya V, Canbakan B, Bali M. Antineutrophil cytoplasmic antibody associated vasculitis and rapidly progressive glomerulonephritis as a complication of propylthiouracil therapy. Clin Endocrinol. 2002;57:699–700.
- Winters MJ, Hurley RM, Lirenman DS. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol. 2002;17:257–260.
- Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron. 1996;74:734–735.
- Yuksel C, Ayli MD, Yuksel A, . Propylthiouracil-induced vasculitis associated with ANCA: a case report. Renal Fail. 2007; 29:235–237.
- Braham A, Houman MH, Rais L, Ben Gborbel I, Lamloum M, Miled M. Benzylthiouracil induced ANCA-positive vasculitis. Presse Med. 2004;33:1331–1333.
- Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves’ disease: report of three adult cases. Am J Kidney Dis. 1995;26:774–780.